In fact, AR antagonists have demonstrated significant therapeutic potential, driving the development of numerous such compounds worldwide offering promising avenues for the treatment of a range of diseases including respiratory and neurodegenerative disorders, neuropathic pain, and cancer [85,86]. The gene discussed is AR; the disease is cancer.